LIPT2 and neonatal encephalopathy: Patients with LIPT2 mutations have been found to present with severe neonatal encephalopathy, decreased PDH and α-KGDH activity, abnormal leucine metabolism, and reduced protein lipoylation in LIPT2-mutated fibroblasts [32].